New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 21, 2013
07:05 EDTCPIXCumberland licenses Caldolor injection to Sandor for India commercialization
Cumberland announced that it has entered into an exclusive agreement with Sandor Medicaids Pvt. Ltd., an India-based pharmaceutical company, for the commercialization of Caldolor Injection in India. Under the terms of the agreement, Sandor Medicaids Pvt. Ltd. is responsible for seeking regulatory approval for Caldolor and, following approval, would handle ongoing distribution and sales in the territory. Cumberland maintains responsibility for product formulation, development and manufacturing, and will provide finished product for sale. In exchange for the license to the product, Cumberland will receive upfront and milestone payments, a transfer price and royalties on future sales of Caldolor.
News For CPIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 23, 2015
16:08 EDTCPIXCumberland launches Caldolor in Australia
Subscribe for More Information
09:22 EDTCPIXCumberland announces approval of Caldolor injection
Cumberland announced the approval of Caldolor Injection for pediatric patients six months of age and older. The approval was based on data submitted to the U.S. Food and Drug Administration (FDA) as part of a post-marketing commitment following approval of Caldolor in adults in 2009. Caldolor is the first and only injectable non-steroidal anti-inflammatory drug approved for use in pediatric patients.
November 20, 2015
09:21 EDTCPIXCumberland announces favorable Acetadote patent ruling
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use